News

Researchers at the Medical Research Council Toxicology Unit have used an orally-administered compound to block a major pathway leading to brain cell death in mice, preventing neurodegeneration.

An international collaboration has shed new light on the origins and molecular causes of age related degenerative conditions including Motor Neurone Disease (MND).

Yale scientists have made dramatic improvement in understanding neirons and electrical activity in cells.

Study could help yield new drugs for brain disorders.

Agendas focus on strengthening regulatory awareness for pharmaceutical and biotechnology professionals in Europe.

The Medicines Patent Pool and healthcare company Roche announce an agreement to increase access to Valcyte (valganciclovir), a key medicine to treat cytomegalovirus (CMV).

New projects will target Fragile X syndrome, nicotine addiction, and age-related macular degeneration.

Scientists have shed light on a critical stage of cell fate differentiation, a discovery which will influence fundamental cell biology and potentially aid our understanding of stem cell biology.

The Centres of Excellence in neurodegenerative disease (CoEN) initiative funds collaborative research in the field of neurodegenerative disease.

Gladstone-led study also finds target that boosts protein clearance, prolongs cell life.